Active surveillance: a future perspective
The New Prostate Cancer InfoLink
by Sitemaster
2y ago
This coming Friday, April 22, at 11:00 am Eastern / 8 am Pacific, there will be an important new educational opportunity for the prostate cancer patient and patient advocacy community: Your Voice in the Future of Active Surveillance, coordinated by Active Surveillance Patients International (ASPI) and supported by many other prostate cancer patient advocacy groups.  ..read more
Visit website
NCCN guidance on initial management of low-risk, localized prostate cancer (redux)
The New Prostate Cancer InfoLink
by Sitemaster
2y ago
In late October, we had commented on the then-latest revision of the National Comprehensive Cancer Network (NCCN)’s guidelines on the initial management of men with low-risk forms of localized prostate cancer. Specifically we had protested the removal of any suggestion that this form of prostate cancer should — preferably — be managed using active surveillance ..read more
Visit website
Projected attendance at AS research conference
The New Prostate Cancer InfoLink
by Sitemaster
2y ago
About 100 patients, clinicians, and others are already registered as attendees at the conference on Developing Provocative Questions: The Prostate Cancer Active Surveillance Research Initiative Click on the link above for more information and to register. There is still plenty of time to join us. The conference will take place from 12:00 pm to 4:00 ..read more
Visit website
Registration for major active surveillance (AS) research conference now open
The New Prostate Cancer InfoLink
by Sitemaster
2y ago
Registration is now OPEN for the upcoming conference on future research into the use of active surveillance for men with favorable-risk forms of localized prostate cancer: Developing Provocative Questions: The Prostate Cancer Active Surveillance Research Initiative Click on the link above for more information and to register. The conference will take place from 12:00 pm ..read more
Visit website
NCCN guidance on the initial management of low-risk, localized prostate cancer
The New Prostate Cancer InfoLink
by Sitemaster
2y ago
As many readers will already be aware, the National Comprehensive Cancer Network (NCCN) has recently removed the word “preferred” from its statement regarding the use of active surveillance (AS) as an appropriate form of management of men with low-risk forms of localized prostate cancer. A broad swath of specialists in the initial management of low-rise ..read more
Visit website
Exceptions to “early salvage” radiation treatment for recurrence after prostatectomy
The New Prostate Cancer InfoLink
by Sitemaster
2y ago
Three major randomized clinical trials and a meta-analysis have proved that for most men waiting for early signs of recurrence after prostatectomy (e.g., three consecutive PSA rises or a PSA of 0.1 ng/ml) to give radiation gave the same outcome as immediate (“adjuvant”) radiation (see this link). But there are exceptions. In some men, adjuvant ..read more
Visit website
Chances to hear from the new President and CEO of the Prostate Cancer Foundation
The New Prostate Cancer InfoLink
by Sitemaster
2y ago
At the end of September, the Prostate Cancer Foundation appointed Charles {“Chuck”) Ryan, MD — formerly of the University of California, San Francisco, and the University of Minnesota — as the new President and CEO of the Foundation. And there will be two opportunities for patients to hear directly from Dr. Ryan in the near ..read more
Visit website
More than 25 organizations join new Prostate Cancer Impact Alliance
The New Prostate Cancer InfoLink
by Sitemaster
2y ago
Prostate Cancer International (PCaI) is proud to be an inaugural member of the new Prostate Cancer Impact Alliance (PCIA). PCIA’s shared vision is to advance education, research and equitable access to high quality care to better patient outcomes for men with prostate cancer. A detailed media release about PCIA was issued by the Urology Care ..read more
Visit website
Educational opportunities on September 29 upcoming
The New Prostate Cancer InfoLink
by Sitemaster
2y ago
Two educational programs are scheduled on Wednesday, September 29. The two programs will be be very different: one for very early stage patients; the other for patients with progressive prostate cancer at risk for (or already diagnosed with) de novo metastatic, hormone-sensitive prostate cancer (mHSPC) The earlier program that evening is being coordinated by the ..read more
Visit website
Whole-pelvic radiation therapy for high-risk patients
The New Prostate Cancer InfoLink
by Sitemaster
2y ago
The decision about whether or not to treat the entire pelvic lymph node area along with the prostate (called whole pelvic radiation therapy or WPRT) or to treat just the prostate with a margin around it (called prostate-only radiation therapy or PORT) has long been a matter of judgment. Now we have proof of its ..read more
Visit website

Follow The New Prostate Cancer InfoLink on FeedSpot

Continue with Google
Continue with Apple
OR